Akadeum Life Sciences Announces New Early Access Launch of


ANN ARBOR, Mich., Sept. 21, 2022 (GLOBE NEWSWIRE) — Akadeum Life Sciences, Inc., a world chief in buoyancy-based cell separation expertise, pronounces a brand new early entry program launch of an industry-first: the Microbubble Leukopak Human T Cell Isolation Kit. This new analysis use-only package was developed with the intention to give scientists a necessary resolution to organic and workflow challenges within the lab. The product combines distinctive benefits of microbubbles with a Buoyancy Activated Cell SortingTM (BACSTM) Separation Tube that’s poised to remodel giant quantity cell separation workflows.

Leukopaks—blood luggage that include billions of extracted white blood cells—are regularly the place to begin for CAR-T remedy and related analysis. While CAR-T therapies are one of probably the most groundbreaking discoveries in drugs, the method depends on giant portions of extremely pure T cells which are remoted from leukopaks. However, this step of isolation will be difficult, requiring hours to course of a single leukopak and leading to low yield.

With standard applied sciences, it could actually take three hours or extra to course of even a single leukopak. With Akadeum’s patented expertise, customers can course of almost two leukopaks in a single hour. Akadeum’s BACSTM Separation Tubes, demonstrated on this video, create timesaving and efficiency advantages with the straightforward separation of goal cells from the rest of the pattern. This not solely reduces time but additionally promotes the well being and physiology of cells. With elevated throughput and fewer pre-processing, scientists can now spend extra time finding out cells than separating them.

“Cell therapy and associated research is transforming medicine. The process of separating valuable cells is a critical step in the workflow that requires immediate attention and solutions,” said Brandon McNaughton, Ph.D., CEO and co-founder of Akadeum. “Our new kit is unlike any other product on the market because of its speed, gentleness and high throughput capability. Our separation processes further enable scientists in accelerating their life-saving cell therapy research.”

See also  lockrMail Announces Email “Digests” to Help Consumers

Akadeum’s line of kits is designed with its patented buoyancy-based microbubble technology at its core. This technology has changed the way researchers work with cells by using flotation to isolate targeted cells gently, effectively and quickly. The technology works by using low-density particles to float targeted cells to the top of a sample, enabling minimal handling, resulting in happy and healthier cells.

This package is launched as Research Use Only (RUO) and will be discovered right here: https://www.akadeum.com/product/microbubble-leukopak-human-t-cell-isolation-kit/.

About Akadeum Life Sciences, Inc.

Akadeum Life Sciences was formed to solve long-standing sample preparation problems in research, diagnostics, and cell therapy markets with a novel flotation-based target isolation platform technology. Without the critical step of separation (isolating biological targets like DNA, proteins, or cells from biological samples), many diagnostics and therapies would not be possible. More than a solution to a single problem, this elegantly simple platform technology is disrupting the separation market—from nucleic acid extraction to cell isolation. The company was the first to commercialize Buoyancy Activated Cell Sorting (BACS™) microbubble kits for cell isolation applications. In parallel, the company is also establishing industry partnerships.

To study extra about Akadeum and its merchandise, go to https://www.akadeum.com.

Inquiries into Akadeum’s merchandise, expertise, or partnership alternatives will be made at info@akadeum.com.

A video accompanying this announcement is obtainable at: https://www.globenewswire.com/NewsRoom/AttachmentNg/40824e9b-41b4-408c-b0aa-0af8f08f82ad

Source link


Please enter your comment!
Please enter your name here